Cancer Medicine

Lenalidomide plus dexamethasone as first-line therapy in transplant-ineligible patients with multiple myeloma

BMC Infectious Diseases

Machine learning triumphs in differentiating fungal and bacterial infections

Blood Advances

BCMA/CD19 dual-targeting CAR T cell therapy in older patients with newly diagnosed multiple myeloma: A phase I study

American Journal of Hematology

The role of bispecific antibodies in relapsed/refractory multiple myeloma with renal impairment: A systematic review

Cancer Control

The changing landscape of second primary malignancies in multiple myeloma: A SEER population-based study between two therapeutic eras

Frontiers in Digital Health

Shaping the future of multiple myeloma with artificial intelligence and digital twins: from concept to clinic

International Journal of Hematology

Anti-CD38-based quadruplet versus triplet induction regimens in transplant-ineligible newly diagnosed multiple myeloma: a systematic review and meta-analysis

Frontiers in Oncology

Morphology-based cytogenetic risk prediction in multiple myeloma from bone marrow smears

Frontiers in Immunology

Tailored strategies for improved control of CAR-T cells in multiple myeloma

Molecular Therapy

CAR-modified marrow infiltrating lymphocytes efficiently target malignant plasma cells with very low antigen density